ZLTQ 26.44 Zeltiq Aesthetics Inc $ZLTQ Hit a 52 week high of 27.50 Closing the day 11/04/14 at 26.44 +0.73 +2.84% With a day low of 25.27 and a total volume of 958,500.
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Zeltiq Aesthetics (ZLTQ) Upgraded From Sell to Hold
at The Street - Mon Nov 03, 9:04AM CST
Zeltiq Aesthetics (ZLTQ) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ZLTQ: 26.44 (+0.73)
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 26.44 (+0.73), TYL: 109.30 (+0.24), SWHC: 10.15 (+0.23)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 26.44 (+0.73), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43), OMI: 33.58 (+0.46)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.41 (-0.11), ZLTQ: 26.44 (+0.73), EA: 40.64 (-0.32), AMED: 26.50 (+0.69)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 26.44 (+0.73), GPRE: 33.62 (-0.96), WMB: 54.17 (-1.51), OMG: 25.68 (-0.25), IPGP: 73.50 (-0.73)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 26.44 (+0.73), MDT: 67.93 (-0.22), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 26.44 (+0.73), ORB: 25.12 (-0.57), FB: 75.76 (+1.88)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 26.44 (+0.73)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 26.44 (+0.73)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 26.44 (+0.73)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 26.44 (+0.73)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 26.44 (+0.73), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43), BAX: 68.45 (-1.23)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 26.44 (+0.73)
ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 26.44 (+0.73), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43), RMD: 51.81 (+0.10)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.14 (+0.09), ZLTQ: 26.44 (+0.73), ABAX: 53.38 (+0.43), RMD: 51.81 (+0.10)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 496.00 (+0.16), ELOS: 9.85 (+0.09), VRX: 133.61 (+0.76), ZLTQ: 26.44 (+0.73), VAR: 84.31 (+0.55), CFN: 57.38 (+0.13), STNR: 41.65 (+0.64)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.14 (+0.09), ZLTQ: 26.44 (+0.73), ABAX: 53.38 (+0.43), CRDC: 0.96 (-0.02)
Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 26.44 (+0.73), PAHC: 26.35 (+0.58), GWPH: 73.32 (-0.79), TRIB: 17.17 (+0.07)
Mead Johnson Tops Q3 Earnings & Revenues, Retains View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 11:59AM CDT
Mead Johnson (MJN) expects dairy input costs to moderate in the near future, which is believed to fuel positive growth in overall profit margins.
ZLTQ: 26.44 (+0.73), MJN: 98.41 (-1.85), GWPH: 73.32 (-0.79), QDEL: 27.72 (-0.49)
Unisys (UIS) Q3 Results Trump Estimates, Shares Shoot Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:04AM CDT
Shares of Unisys Corporation (UIS) shot up sharply after it reported impressive third-quarter 2014 results, breaking its trend after several quarters of missing estimates amid deteriorating earnings and revenues.
ZLTQ: 26.44 (+0.73), WTM: 618.62 (-5.10), UIS: 25.94 (-0.31), THRM: 39.74 (-1.23)
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Zeltiq Aesthetics (ZLTQ) Upgraded From Sell to Hold
at The Street - Mon Nov 03, 9:04AM CST
Zeltiq Aesthetics (ZLTQ) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ZLTQ: 26.44 (+0.73)
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 26.44 (+0.73), TYL: 109.30 (+0.24), SWHC: 10.15 (+0.23)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 26.44 (+0.73), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43), OMI: 33.58 (+0.46)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.41 (-0.11), ZLTQ: 26.44 (+0.73), EA: 40.64 (-0.32), AMED: 26.50 (+0.69)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 26.44 (+0.73), GPRE: 33.62 (-0.96), WMB: 54.17 (-1.51), OMG: 25.68 (-0.25), IPGP: 73.50 (-0.73)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 26.44 (+0.73), MDT: 67.93 (-0.22), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 26.44 (+0.73), ORB: 25.12 (-0.57), FB: 75.76 (+1.88)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 26.44 (+0.73)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 26.44 (+0.73)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 26.44 (+0.73)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 26.44 (+0.73)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 26.44 (+0.73), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43), BAX: 68.45 (-1.23)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 26.44 (+0.73)
ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 26.44 (+0.73), GWPH: 73.32 (-0.79), ABAX: 53.38 (+0.43), RMD: 51.81 (+0.10)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.14 (+0.09), ZLTQ: 26.44 (+0.73), ABAX: 53.38 (+0.43), RMD: 51.81 (+0.10)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 496.00 (+0.16), ELOS: 9.85 (+0.09), VRX: 133.61 (+0.76), ZLTQ: 26.44 (+0.73), VAR: 84.31 (+0.55), CFN: 57.38 (+0.13), STNR: 41.65 (+0.64)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.14 (+0.09), ZLTQ: 26.44 (+0.73), ABAX: 53.38 (+0.43), CRDC: 0.96 (-0.02)
Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 26.44 (+0.73), PAHC: 26.35 (+0.58), GWPH: 73.32 (-0.79), TRIB: 17.17 (+0.07)
Mead Johnson Tops Q3 Earnings & Revenues, Retains View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 11:59AM CDT
Mead Johnson (MJN) expects dairy input costs to moderate in the near future, which is believed to fuel positive growth in overall profit margins.
ZLTQ: 26.44 (+0.73), MJN: 98.41 (-1.85), GWPH: 73.32 (-0.79), QDEL: 27.72 (-0.49)
Unisys (UIS) Q3 Results Trump Estimates, Shares Shoot Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:04AM CDT
Shares of Unisys Corporation (UIS) shot up sharply after it reported impressive third-quarter 2014 results, breaking its trend after several quarters of missing estimates amid deteriorating earnings and revenues.
ZLTQ: 26.44 (+0.73), WTM: 618.62 (-5.10), UIS: 25.94 (-0.31), THRM: 39.74 (-1.23)
